Rohto Laboratories Indonesia is primarily engaged in pharmaceutical preparations, nec activity. Its headquarters is located in Dki Jakarta. The company was founded in 1996. Rohto Laboratories Indonesia is a subsidiary of Rohto Pharmaceutical Co., Ltd., a renowned Japanese company founded by Yasutami Yamada in 1899. The company is well-known for its innovative healthcare and cosmetic products. In Indonesia, Rohto Laboratories focuses on the production and distribution of a wide range of pharmaceutical and cosmetic products, including eye drops, skincare products, and over-the-counter medications. The company operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. Rohto Laboratories Indonesia is committed to maintaining high standards of quality and safety in its manufacturing processes, adhering to both local and international regulations. Globally, Rohto Pharmaceutical Co., Ltd. has a significant presence, with operations in over 150 countries. The company is known for its popular brands such as Rohto Eye Drops, Mentholatum, and Hada Labo, which are widely recognized and trusted by consumers worldwide. Rohto Laboratories Indonesia collaborates with various local and international partners to enhance its product offerings and expand its market reach. The company is a member of several industry associations, actively participating in initiatives to promote health and wellness. With a vision to improve the quality of life through innovative healthcare solutions, Rohto Laboratories Indonesia continues to invest in research and development, aiming to introduce new and effective products that cater to the evolving needs of consumers.
Headquarters
Kota Jakarta Barat Slipi Palmerah Dki Jakarta
West Jakarta; Jakarta;
Postal Code: 11410
Contact Details: Purchase the PT Rohto Laboratories Indonesia report to view the information.
Website: http://www.rohto.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service